A class-action lawsuit filed in August accuses Moderna of making “materially false and misleading statements” about the efficacy of its RSV shot, leading to significant damages for investors.
A class-action lawsuit filed in August accuses Moderna of making “materially false and misleading statements” about the efficacy of its RSV shot, leading to significant damages for investors.
